. 2017 Apr 7;21:16-102. doi: 10.7812/TPP/16-102

Table 4.

Marginal effects (standard errors) of changing Drug A characteristics

Variable	ΔP: Drug A selected	ΔP: Drug B selected	ΔP: No drug selected
Marginal effect of changing dosage modality from oral 1x/d to:
Oral 2x/d	−0.013 (0.025)	0.003 (0.005)	0.011 (0.020)
Injection 1x/wk	−0.080 (0.021)^a	0.015 (0.004)^a	0.065 (0.017)^a
Injection 1x/d	−0.076 (0.025)^a	0.014 (0.005)^a	0.061 (0.020)^a
Infusion 1x/mo	−0.097 (0.023)^a	0.018 (0.004)^a	0.079 (0.019)^a
Marginal effect of changing efficacy domain from improvement mentally/emotionally to:
How you feel physically	0.027 (0.029)	−0.004 (0.005)	−0.023 (0.024)
How you function physically	0.077 (0.025)^a	−0.013 (0.004)^a	−0.064 (0.021)^a
Mentally/emotionally and how you feel physically	0.067 (0.029)^b	−0.011 (0.005)^b	−0.056 (0.024)^b
Mentally/emotionally and how you function physically	0.116 (0.029)^a	−0.021 (0.005)^a	−0.096 (0.024)^a
How you feel and function physically	0.068 (0.028)^b	−0.011 (0.005)^b	−0.056 (0.024)^b
All three domains	0.174 (0.030)^a	−0.033 (0.006)^a	−0.141 (0.025)^a
Marginal effect of changing from risk of mild relapse to:
Risk of moderate relapse	−0.113 (0.020)^a	0.022 (0.004)^a	0.090 (0.016)^a
Risk of severe relapse	−0.251 (0.019)^a	0.043 (0.004)^a	0.207 (0.016)^a
Marginal effect of changing from relatively few side effects to:
Risk of cardiopulmonary side effects	−0.282 (0.029)^a	0.054 (0.006)^a	0.228 (0.024)^a
Risk of skin-related side effects	−0.129 (0.025)^a	0.028 (0.005)^a	0.100 (0.020)^a
Risk of flulike symptoms	−0.194 (0.025)^a	0.040 (0.005)^a	0.154 (0.020)^a
Risk of neurologic side effects	−0.303 (0.023)^a	0.056 (0.005)^a	0.247 (0.019)^a

p < 0.01.

p < 0.05.

Δ = change.